Free Trial

Hims & Hers Health (HIMS) Competitors

Hims & Hers Health logo
$22.28 +0.49 (+2.25%)
(As of 09:04 AM ET)

HIMS vs. FMS, GH, SHC, OPCH, BTSG, VCYT, SGRY, LFST, CON, and PACS

Should you be buying Hims & Hers Health stock or one of its competitors? The main competitors of Hims & Hers Health include Fresenius Medical Care (FMS), Guardant Health (GH), Sotera Health (SHC), Option Care Health (OPCH), BrightSpring Health Services (BTSG), Veracyte (VCYT), Surgery Partners (SGRY), LifeStance Health Group (LFST), Concentra Group Holdings Parent (CON), and PACS Group (PACS). These companies are all part of the "healthcare" industry.

Hims & Hers Health vs.

Fresenius Medical Care (NYSE:FMS) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, earnings, valuation, community ranking, profitability, risk and dividends.

Fresenius Medical Care has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.06, indicating that its share price is 6% more volatile than the S&P 500.

Hims & Hers Health has a net margin of 8.19% compared to Fresenius Medical Care's net margin of 3.43%. Hims & Hers Health's return on equity of 10.97% beat Fresenius Medical Care's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care3.43% 6.04% 2.69%
Hims & Hers Health 8.19%10.97%8.29%

8.3% of Fresenius Medical Care shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Fresenius Medical Care has higher revenue and earnings than Hims & Hers Health. Fresenius Medical Care is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care$21.05B0.61$540.07M$1.2118.01
Hims & Hers Health$872M5.46-$23.55M$0.4449.55

Fresenius Medical Care received 383 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 54.69% of users gave Fresenius Medical Care an outperform vote while only 37.37% of users gave Hims & Hers Health an outperform vote.

CompanyUnderperformOutperform
Fresenius Medical CareOutperform Votes
420
54.69%
Underperform Votes
348
45.31%
Hims & Hers HealthOutperform Votes
37
37.37%
Underperform Votes
62
62.63%

Fresenius Medical Care currently has a consensus target price of $24.30, suggesting a potential upside of 11.52%. Hims & Hers Health has a consensus target price of $20.71, suggesting a potential downside of 4.98%. Given Fresenius Medical Care's higher possible upside, equities analysts plainly believe Fresenius Medical Care is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Hims & Hers Health
1 Sell rating(s)
8 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.38

In the previous week, Hims & Hers Health had 28 more articles in the media than Fresenius Medical Care. MarketBeat recorded 32 mentions for Hims & Hers Health and 4 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 1.46 beat Hims & Hers Health's score of 0.26 indicating that Fresenius Medical Care is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hims & Hers Health
9 Very Positive mention(s)
7 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Hims & Hers Health beats Fresenius Medical Care on 11 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HIMS vs. The Competition

MetricHims & Hers HealthOffices & clinics of medical doctors IndustryMedical SectorNYSE Exchange
Market Cap$5.14B$950.65M$5.06B$19.87B
Dividend YieldN/AN/A4.97%3.50%
P/E Ratio49.556.1989.0235.66
Price / Sales5.461.381,207.2817.95
Price / CashN/A43.2039.1717.98
Price / Book10.852.956.084.59
Net Income-$23.55M-$52.07M$119.07M$985.93M
7 Day Performance4.58%-9.44%-1.84%0.45%
1 Month Performance-5.44%-11.03%-3.65%1.05%
1 Year Performance187.22%-13.01%31.62%24.67%

Hims & Hers Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HIMS
Hims & Hers Health
3.5694 of 5 stars
$22.28
+2.2%
$20.71
-7.0%
+181.8%$4.87B$872M50.641,046Analyst Forecast
Insider Trade
FMS
Fresenius Medical Care
3.9521 of 5 stars
$21.96
+0.8%
$24.30
+10.7%
+11.1%$12.89B$21.05B18.011,358Positive News
GH
Guardant Health
4.2853 of 5 stars
$30.90
+0.7%
$40.60
+31.4%
+28.4%$3.82B$563.95M0.001,779
SHC
Sotera Health
3.6657 of 5 stars
$13.21
-2.9%
$16.50
+24.9%
-5.2%$3.74B$1.05B52.843,000High Trading Volume
OPCH
Option Care Health
4.9784 of 5 stars
$21.88
+0.3%
$30.83
+40.9%
-26.3%$3.72B$4.30B18.397,802Positive News
BTSG
BrightSpring Health Services
2.9593 of 5 stars
$18.83
+0.2%
$16.79
-10.8%
N/A$3.28B$8.83B0.0035,000Positive News
VCYT
Veracyte
4.1264 of 5 stars
$39.19
0.0%
$41.25
+5.3%
+50.5%$3.04B$361.05M-261.33790Analyst Forecast
SGRY
Surgery Partners
3.0985 of 5 stars
$22.55
+0.2%
$38.71
+71.7%
-29.9%$2.87B$2.74B-46.9013,500Analyst Forecast
LFST
LifeStance Health Group
1.7849 of 5 stars
$7.22
-0.3%
$8.50
+17.7%
+16.5%$2.76B$1.06B0.009,325
CON
Concentra Group Holdings Parent
N/A$21.27
+4.9%
$28.50
+34.0%
N/A$2.71B$1.84B0.0011,000Gap Up
High Trading Volume
PACS
PACS Group
4.0685 of 5 stars
$17.71
+2.7%
$39.88
+125.2%
N/A$2.70B$3.11B0.0032,433Analyst Forecast

Related Companies and Tools


This page (NYSE:HIMS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners